L01EX17 capmatinib
ATC group of level 5 – chemical substance · in plain English: targeted cancer medicines (kinase inhibitors)
This site has the patient leaflet or the SPC of 1 medicine in this group.
Place in the ATC classification
- L Antineoplastic and immunomodulating agents 1,791 medicines
- L01 Antineoplastic agents 1,025 medicines
- L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents 353 medicines
- L01EX Other protein kinase inhibitors 94 medicines
- L01EX17 capmatinib 1 medicine
- L01EX Other protein kinase inhibitors 94 medicines
- L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents 353 medicines
- L01 Antineoplastic agents 1,025 medicines
Medicines
| Medicine | Legal category |
|---|---|
| Tabrecta 200 mg film-coated tablets SPC | – |
Other groups of the same level
- L01EX01 sunitinib 37 medicines
- L01EX02 sorafenib 6 medicines
- L01EX03 pazopanib 4 medicines
- L01EX04 vandetanib 2 medicines
- L01EX05 regorafenib 1 medicine
- L01EX07 cabozantinib 8 medicines
- L01EX08 lenvatinib 7 medicines
- L01EX09 nintedanib 12 medicines
- L01EX10 midostaurin 1 medicine
- L01EX11 quizartinib 1 medicine
- L01EX12 larotrectinib 3 medicines
- L01EX13 gilteritinib 1 medicine
- L01EX14 entrectinib 2 medicines
- L01EX18 avapritinib 5 medicines
- L01EX19 ripretinib 1 medicine
- L01EX20 pemigatinib 1 medicine
- L01EX21 tepotinib 1 medicine
Other names of the ATC group
- German: L01EX17 Capmatinib
- German: L01EX17 Capmatinib
- Turkish: L01EX17 kapmatinib
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group L01EX17
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.